Looking for leads, investment insights, or competitive intelligence?
News about Amgen
Novartis and Amgen want to find out with an experimental drug.
The FDA approved the first cancer medicine "biosimilar" Thursday.
Scientists are ready to move an experimental treatment into phase 1 trials.
Coherus BioSciences shares took a massive hit on Monday.
Critics accused the Charging Bull's new Wall Street companion of being an advertisement in disguise.